Unprotected Lease AgreementLease Agreement • June 9th, 2015 • Intec Pharma Ltd. • Pharmaceutical preparations
Whereas the Lessor represents that it has signed a long-term lease agreement with the Israel Land Administration in respect of the land known as Lot No. 14 in Har Hotzvim B in Jerusalem –Zoning Plan 3760 A (the "Land"); and
INTEC PHARMA LTD. EMPLOYMENT AGREEMENT With Nadav NavonEmployment Agreement • June 9th, 2015 • Intec Pharma Ltd. • Pharmaceutical preparations
AGREEMENT entered into as of between Nadav Navon, residing at 7 Socholovsky Zvi St., Rechovot, Israel (the “Employee”), and Intec Pharma Ltd., an Israeli company with offices located at 10 Hertom St. Har Ha’hozvim, Jerusalem, Israel (the “Company”).
AgreementEmployment Agreement • June 9th, 2015 • Intec Pharma Ltd. • Pharmaceutical preparations
Whereas The agreement by virtue of which the Executive is serving as the Company’s manager dated July 31, 2006 has expired (the “Former Employment Agreement”), and is null and void, other than as specified in the Company’s side letter to the Executive attached hereto as Annex A (the “Side Letter”); and
Employment Agreement Entered into and executed in Jerusalem on November 25, 2013 Between Intec Pharma Ltd. Private Company 513022780 of 12 Hartom st. P.O. Box 45219 Jerusalem 91450 (the "Company")Employment Agreement • June 9th, 2015 • Intec Pharma Ltd. • Pharmaceutical preparations
Whereas The Employee has expressed his will to be employed by the Company in the office of a VP Business Development and Medical Affairs (the "Office"), and under the other terms specified in this Agreement below; and
NOTE: PORTIONS OF THIS EXHIBIT ARE THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST BY THE REGISTRANT TO THE SECURITIES AND EXCHANGE COMMISSION (“COMMISSION”). SUCH PORTIONS HAVE BEEN REDACTED AND FILED SEPARATELY WITH THE COMMISSION AND ARE MARKED...Research, Option and License Agreement • June 9th, 2015 • Intec Pharma Ltd. • Pharmaceutical preparations • New York
This RESEARCH, OPTION AND LICENSE AGREEMENT (this “Agreement”) is entered into as of April 15, 2015 (the “Effective Date”) by and between INTEC PHARMA LTD., with offices located at 12 Hartom St., P.O.B 45219, Jerusalem 91450 (“Intec Pharma”) and “[***]” with offices located at “[***]”, Massachusetts, “[***]” USA “[***]”. Each of Intec Pharma and “[***]” is sometimes referred to individually herein as a “Party” and collectively as the “Parties.”
AMENDMENTJoint Venture for R&d Agreement • June 9th, 2015 • Intec Pharma Ltd. • Pharmaceutical preparations
THIS AMENDMENT (the “Amendment”) made on 13 day of July 2005 by and between Yissum Research Development Company of the Hebrew University of Jerusalem (“Yissum”), and Intec Pharma Ltd. (formerly Intec Pharmaceutical Partnership Ltd.) (“Intec Pharma”) (each a “Party” and together the “Parties”).
SUBSCRIPTION AGREEMENTSubscription Agreement • June 9th, 2015 • Intec Pharma Ltd. • Pharmaceutical preparations
Y equals the number of Ordinary Shares which would otherwise have been purchasable under the portion of such Subscriber's Warrant being exercised, at the time of exercise pursuant to this formula (or the portion thereof being canceled);
